(Q34594736)

3 August 2017

1 reference

title

Kaposi sarcoma in transplantation (English)

1 reference

3 August 2017

Céleste Lebbé

1

1 reference

3 August 2017

Christophe Legendre

series ordinal

2

1 reference

3 August 2017

Camille Francès

series ordinal

3

1 reference

3 August 2017

publication date

24 July 2008

1 reference

3 August 2017

published in

Transplantation Reviews

1 reference

3 August 2017

volume

22

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

252-261

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

3 August 2017

1 reference

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Very early appearance of Kaposi's sarcoma after cardiac transplantation in Sephardic Jews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Treatment of Kaposi's sarcoma after solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Aspects épidémiologiques de l'herpèsvirus humain 8 (HHV-8) et du sarcome de Kaposi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma in recipients of renal transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Skin cancers after organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma in liver transplant recipients: morphological and clinical description

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Outcome of kidney transplant recipients with previous human herpesvirus-8 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Human herpes-virus 8 seropositive patient with skin and graft Kaposi's sarcoma after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

HUMAN HERPESVIRUS-8 SEROCONVERSIONS AFTER RENAL TRANSPLANTATION1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Regression of post-transplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Maintenance pharmacological immunosuppressive strategies in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma in cyclosporine-induced gingival hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Imaging manifestations of Kaposi sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Prognostic Value of Quantitative Kaposi Sarcoma–Associated Herpesvirus Load in Posttransplantation Kaposi Sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Posttransplant Kaposi sarcoma: staging as a guide to therapy and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Posttransplantation Plasmacytic Proliferations Related to Kaposi's Sarcoma–Associated Herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

KSHV- and EBV-associated germinotropic lymphoproliferative disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Bone marrow failure associated with human herpesvirus 8 infection after transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

The pleiotropic effects of Kaposi's sarcoma herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Comparison of serologic assays for detection of antibodies against human herpesvirus 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Virologic and Immunologic Parameters that Predict Clinical Response of AIDS-Associated Kaposi's Sarcoma to Highly Active Antiretroviral Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Evidence for a Multiclonal Origin of Multicentric Advanced Lesions of Kaposi Sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Structure and function of latency-associated nuclear antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Insights into the viral G protein-coupled receptor encoded by human herpesvirus type 8 (HHV-8).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Immune evasion by Kaposi's sarcoma-associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi sarcoma in solid organ transplant recipients: a single center report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Sirolimus conversion for patients with posttransplant Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Reccurence of Kaposi's sarcoma after increased exposure to sirolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Sirolimus for Kaposi's sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Interferon-alpha-induced acute renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Successful secondary prophylaxis for primary effusion lymphoma with human herpesvirus 8 therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

No recurrence of Kaposi's sarcoma in a case of renal retransplantation under a calcineurin inhibitor free immunosuppressive regimen: first report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

Kaposi's sarcoma occurring de novo in the surgical scar in a heart transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

KSHV after an organ transplant: should we screen?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.05.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRRE.2008.05.004

1 reference

3 August 2017

1 reference